Professor Dr. Martin J. van den Bent
Brain Tumor Center at Erasmus MC Cancer Center
Rotterdam, the Netherlands
Prof dr Martin J. van den Bent is a trained neurologist from the Netherlands. He joined in 1992 the Neuro-Oncology Unit of Erasmus MC Cancer Center in Rotterdam, the Netherlands. With chemotherapy of brain tumors still in its infancy, he developed a successful program on medical treatment of primary brain tumors. In 2002 he became the head of the Neuro-Oncology unit, which was integrated in 2013 with the Neurosurgery program on brain tumors into the Brain Tumor Center at Erasmus MC Cancer Center. In 2007 he became professor of Neuro-Oncology at Erasmus University. He has been the principle investigator of many international multicenter phase II and III trials on both high and low grade glial tumors, most of which were conducted through the EORTC Brain Tumor Group. Many of these trials included translational research focusing on the identification of prognostic and predictive molecular parameters of outcome to treatment, and which were key in the establishment of the standard of care of diffuse glioma. From 2003 to 2009 he was the chair of the internationally well recognized EORTC Brain Tumor Group . Between 2013 and 2016 he was the chair of the EORTC Clinical Research Division, and he is currently member of the EORTC Board. In 2015 he received the ECCO Clinical Research Award. Prof van den Bent has published widely both on the treatment of primary brain tumors and on neurological complications of systemic cancers. He wrote many chapters in textbooks on neuro-oncology, and is one of the coordinating members of the Response Assessment in Neuro-Oncology (RANO) group revising the endpoints and response criteria of trials in neuro-oncology.